Japan: Regulatory Compliance Requirements for Life Science Products


Instructor: Robert J Russell
Product ID: 702979
Training Level: Intermediate

  • Duration: 90 Min
This training on Japanese regulatory compliance requirements will explain the country's regulations and processes (including clinical trials, filings, etc.) and use real world experiences to show how compliance issues are culturally handled for life science products in Japan.
Last Recorded Date: Aug-2019


1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section
(For multiple locations contact Customer Care)

Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days
(For multiple locations contact Customer Care)



Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

Why Should You Attend:

If your job responsibilities require you to have knowledge of Japan’s regulatory requirements, ensuring compliance with regulatory filings and overall GCP, GMP and GLP compliance requirements or understand how best to consider Japan into your Global Business Strategy, then you will profit from attending our training.

This webinar will help you gain a comprehensive understanding of the Regulatory Structure, Clinical Trial Requirements, Marketing Authorization Procedures, Variations Processing, License Renewals and cultural working aspects within the Regulatory Environment in Japan. It will prepare you for regulatory approval processes, Agency meetings, the complexities of running studies in Japan, the importance of partner selection and will also add the cultural knowledge needed for success. The recent changes made by PMDA to be more sponsor and applicant-friendly will be reviewed. Real world experiences on actual interactions with the Agency since these changes were implemented, will also be discussed.

Course Agenda/ Areas Covered:

Part I: Japan Regulatory Compliance

  • Japan’s Regulatory Structure for the Life Science Product Industries
    • Country Healthcare System
    • Regulatory Framework: Key Agencies Involved / Reporting Structure
      • MHLW (Ministry of Health, Labour and Welfare)
      • PMDA (Pharmaceutical and Medical Device Agency)
      • MoH Consulting Committees
      • Consensus Decision-Making: Strengths, Timeline Impacts
    • Patent System
    • Pharmaceutical Affairs Law (PAL)
  • Beginning Your Company Involvement in Japan
    • Local Office and Personnel Requirements
    • Language Requirements
    • License Types
    • Options for Importers / Overseas Manufacturers
  • Objectives of the Rules Governing Medicinal Procedures
    • Life Science Regulations and the Regulatory Processes in Japa
      • Conducting Clinical Trials
      • New Product Registrations
      • Handling of Risk Management
      • Variations to Licenses
      • Post-Marketing Requirements
      • License Renewals
  • Japan’s Use of ICH Standards / Principles
    • GCP
    • GMP
    • Quality Documents and Standards
    • CTD / e-CTD Submissions
  • Starting-Up and Conducting Clinical Trials
    • Who can conduct Clinical Trials?
    • When are they needed?
    • Start-up Process & Timelines

Part II: Marketing Authorization Processes – Product Registrations / Licensing

    • Drugs
    • Medical Devices
    • Biologics
    • Combination Product
    • Drug Master File (DMF) Use in Japan
    • Labeling Requirements
    • Packaging Information Leaflets
  • Variations: Changes to Marketed Products
    • Types of Variations
    • Dossier Maintenance Expectations
  • License Renewals
    • Process and timing for Renewing Licenses
  • Comparing and Contrasting Japan’s Procedures vs. U.S. FDA
    • Comparison of Processes
    • Expected Timelines
    • Accepted Practices
  • How and When to Influence the Regulatory Process
    • Japanese Way of Thinking / Cultural Issue
    • Effective Approaches to Meet Regulators
    • The Do’s and Don’ts of Regulatory Involvement in Japan
    • Utilizing Local Regulatory Resources

Recently Asked Questions:

  1. What determines if a notification needs to be sent to the PMDA if there is a change to the product? There have been no decision trees released by Japan unlike the US and Canada.

Who will Benefit:

  • Clinical / Pharma & Device personnel
  • Clinical Trial Project Managers
  • Monitors / CRAs
  • QA / QC Personnel
  • Pharmacovigilance reporting personnel
  • Regulatory personnel whose responsibilities require knowledge of Japan's Regulatory and Clinical Trial environment
  • Global Supply Chain personnel
  • Manufacturing personnel
  • Global Business Development personnel
Instructor Profile:
Robert J Russell

Robert J Russell
President, RJR Consulting, Inc

For the past 9 years, Robert J. Russell has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.

Follow us :



Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).




6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube


Copyright © 2023 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method